The clinical program of CLL is rather heterogeneous, starting from a reasonably asymptomatic ailment which could even regress spontaneously into a progressive condition that at some point results in the affected person’s death, so there has always been extraordinary fascination in deciding the prognosis of personal individuals. Even though lots o